Internal Medicine, Gastroenterology · Baltimore, MD
NPI
1619014214
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6565 N Charles St, Suite 512
Baltimore, MD, 21204
Phone (443) 849-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,114 services
Medicare patients, 2024
668
Average age 73
Drug cost, 2024
$808K
1,142 prescriptions
Company payments, 2025
$1,584
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael I Asike was code 99213 (office e&m - established), 179 times for 150 patients. In total Michael I Asike billed 1,114 services in 48 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 179 | 150 | $69.43 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 158 | 156 | $210.60 | $33K |
| 43239 Upper GI Endoscopy | Facility | 93 | 91 | $80.16 | $7,455 |
| 99214 Office E&M - Established | Office | 93 | 77 | $100.43 | $9,340 |
| 99222 Hospital E&M - Initial | Facility | 71 | 70 | $106.31 | $7,548 |
| 45380 Lower GI Endoscopy - Other | Facility | 60 | 60 | $109.05 | $6,543 |
| 99204 Office E&M - New | Office | 55 | 55 | $129.39 | $7,117 |
| 99212 Office E&M - Established | Office | 52 | 49 | $42.04 | $2,186 |
| 43235 Upper GI Endoscopy | Facility | 49 | 48 | $81.91 | $4,013 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 40 | 40 | $187.96 | $7,518 |
| 99203 Office E&M - New | Office | 33 | 33 | $72.83 | $2,403 |
| 45378 Lower GI Endoscopy - Other | Facility | 25 | 25 | $122.45 | $3,061 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 24 | 24 | $184.90 | $4,438 |
| 91035 Test - Miscellaneous | Facility | 13 | 13 | $60.52 | $787 |
| 43255 Upper GI Endoscopy | Facility | 13 | 12 | $162.04 | $2,107 |
By year: 2022 $100K for 952 services; 2023 $112K for 1,036 services; 2024 $123K for 1,114 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael I Asike prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 152 prescriptions and refills. In total Michael I Asike wrote 1,142 Medicare prescriptions that cost $808K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 152 | 152 | 151 | $9,258 |
| Omeprazole Generic | 150 | 406 | 74 | $2,343 |
| Pantoprazole Sodium Generic | 107 | 280 | 43 | $2,096 |
| Famotidine Generic | 80 | 211 | 30 | $1,192 |
| Creon Lipase/Protease/Amylase | 39 | 67 | 11 | $147K |
| Dexlansoprazole Dr Dexlansoprazole | 30 | 52 | Under 11 | $6,511 |
| Esomeprazole Magnesium Generic | 25 | 75 | Under 11 | $2,892 |
| Amitriptyline Hcl Generic | 25 | 73 | Under 11 | $451 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 22 | 22 | Under 11 | $338 |
| Dicyclomine Hcl Generic | 21 | 23 | 20 | $461 |
| Cholestyramine Light Cholestyramine | 21 | 37 | Under 11 | $1,095 |
| Sucralfate Generic | 20 | 40 | 13 | $1,046 |
| Nortriptyline Hcl Generic | 20 | 22 | Under 11 | $191 |
| Lactulose Generic | 19 | 22 | Under 11 | $525 |
| Linzess Linaclotide | 18 | 40 | Under 11 | $21K |
Brand drugs: 246 claims; generic drugs: 896 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael I Asike $1,584 ($1,584 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $358.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $358 |
| Madrigal Pharmaceuticals MDGL | 11 | $243 |
| Genzyme Corporation SNY | 6 | $173 |
| Janssen Biotech, Inc. JNJ | 7 | $138 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $73.91 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $71.22 |
| Gilead Sciences, Inc. GILD | 3 | $67.25 |
| Pfizer Inc. PFE | 3 | $60.37 |
| Lilly USA, LLC LLY | 2 | $51.2 |
| Celltrion USA Inc. 068270.KS | 3 | $48.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.